Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2025-12-31 @ 3:37 PM
Study NCT ID:
NCT05444933
Status:
COMPLETED
Last Update Posted:
2023-07-18
First Post:
2022-06-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Collect Pre-existing Data on the Administration of Cabozantinib in Participants With Advanced Renal Cell Carcinoma (aRCC) Who Initiated Cabozantinib in 2nd Line in a Real-life Clinical Setting in France.
Sponsor:
Ipsen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-16
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-12
Completion Date Type:
ACTUAL
First Submit Date:
2022-06-30
First Submit QC Date:
None
Study First Post Date:
2022-07-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-17
Last Update Post Date:
2023-07-18
Last Update Post Date Type:
ACTUAL